, Tracking Stock Market Picks
Enter Symbol:
CareFusion Corporation (CFN) [hlAlert]

up 147.45 %

CareFusion Corporation (CFN) rated Buy with price target $28 by Auriga

Posted on: Thursday,  Jan 26, 2012  11:25 AM ET by Auriga

Auriga rated Buy CareFusion Corporation (NYSE: CFN) on 01/26/2012, when the stock price was $24.21. Since
then, CareFusion Corporation has gained 147.46% as of 03/16/2015's recent price of $59.91.
If you would have followed this Auriga's recommendation on CFN, you would have gained 147.45% of your investment in 1145 days.

CareFusion Corporation (CareFusion) is a global medical technology company. The Company offers product lines in the areas of intravenous (IV) infusion, medication and supply dispensing, respiratory care, infection prevention and surgical instruments. Its primary product brands include Alaris IV infusion systems that feature its Guardrails software, an application that alerts the clinician when a parameter is outside the institution?s pre-established limitations for that medication, thereby helping to reduce IV medication errors; Pyxis automated medication dispensing systems that provide medication management and Pyxis automated medical supply dispensing systems; AVEA and Pulmonetic Systems ventilation and respiratory products, and Jaeger and SensorMedics pulmonary products, and ChloraPrep products that help prevent vascular and surgical-site infections and MedMined software and surveillance services that help target and reduce hospital-acquired infections.

Auriga operates full-service institutional equity and fixed income trading desks with state-of-the-art communications technology and trading systems. Through our U.S. corprate parent, Auriga Holdings, LLC we offer a variety of services including whole loan trading and asset management. Through our Spanish parent company, Auriga Securities Sociedad de Valores, S.A., we offer the ability to trade European equity and fixed income products. We connect electronically to buy-side firms; route orders to multiple points of execution and subsequently route to our clearing firm, Pershing, for settlement.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/26/2012 11:25 AM Buy
24.21 28.00
as of 12/31/2012
1 Week down  -0.38 %
1 Month up  2.36 %
3 Months up  0.66 %
1 YTD up  18.05 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy